Protagenic Therapeutics, Inc. (PTIX)
0.45
+0.03
(+7.02%)
USD |
OTCM |
Feb 23, 15:48
Protagenic Therapeutics Research and Development Expense (Quarterly) : 0.2732M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 434.00M |
| Vanda Pharmaceuticals, Inc. | 29.01M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.59M |